Zobrazeno 1 - 10
of 28
pro vyhledávání: '"N. V. Zabolotnykh"'
Autor:
A.-P. S. Shurygina, N. V. Zabolotnykh, T. I. Vinogradova, K. A. Vasilyev, Zh. V. Buzitskaya, M. A. Stukova
Publikováno v:
Инфекция и иммунитет, Vol 10, Iss 3, Pp 506-514 (2020)
Improving specific prevention of tuberculosis continues to be a top priority in phthisiology. “Prime-boost” vaccination schemes aim to maintain adequate levels of specific immunity while forming long-term protection. They are based on sequential
Externí odkaz:
https://doaj.org/article/84d500ff85fa4bf780fac9a74a68727c
Autor:
J. A. Bespyatykh, Т. I. Vinogradova, O. A. Manicheva, N. V. Zabolotnykh, M. Z. Dogonadze, M. L. Vitovskaya, A. S. Guliaev, V. Yu. Zhuravlev, E. A. Shitikov, E. N. Ilina
Publikováno v:
Инфекция и иммунитет, Vol 9, Iss 1, Pp 173-182 (2019)
Mycobacterium tuberculosis Beijing genotype strains comprise 50–80% in Russian Federation, which are divided into the main B0/W148, CladeA, and CAO clusters based on VNTR and SNP analysis. It should be noted that such phylogenetically highly close
Externí odkaz:
https://doaj.org/article/dc7cc046fdb94b4c9cde45e95ecaab68
Autor:
M. L. Vitovskaya, N. V. Zabolotnykh, T. I. Vinogradova, S. N. Vasilyeva, A. S. Kaftyrev, B. M. Ariel, E. S. Kirillova, T. A. Novitskaya, S. V. Iskrovskiy, M. S. Serdobintsev
Publikováno v:
Travmatologiâ i Ortopediâ Rossii, Vol 0, Iss 3, Pp 80-87 (2013)
The effect of Roncoleukin on the recovery of the bone tissue in plastic operational defects (autobone+OsteoSet-T) on the model of experimental tuberculous osteites in 36 rabbits caused by drug resistant clinical strains of M. tuberculosis was studied
Externí odkaz:
https://doaj.org/article/2a257be8978e4ce3a5a5a20cc100453b
Autor:
I. V. Krasilnikov, T. I. Vinogradova, M. Djonovic, N. V. Zabolotnykh, S. A. Arakelov, M. Z. Dogonadze, V. G. Lunin
Publikováno v:
Genes & Cells. 17:47-55
Incomplete protection of BCG vaccines, high variability of tuberculosis strains, together with the growing antibiotic resistance of mycobacterium tuberculosis, actualize the need to develop new anti-tuberculosis vaccines. Several novel experimental c
Autor:
P K Yablonskiy, T I Vinogradova, Yu N Levashev, M V Pavlova, E K Zilber, A A Starshinova, N V Sapozhnikova, I V Chernokhaeva, L I Archakova, N V Zabolotnykh, M L Vitovskaya
Publikováno v:
Терапевтический архив, Vol 88, Iss 3, Pp 111-115 (2016)
The paper sets forth the stages of design and introduction of the new Russian tuberculosis (TB) drug perchlozon registered in the Russian Federation in 2012. Based on the results of Phases I-III clinical trials, the authors evaluate the efficacy and
Externí odkaz:
https://doaj.org/article/fb038c632bd145359e573e43d0d89e97
Autor:
T I, Vinogradova, M L, Vitovskaia, N V, Zabolotnykh, A L, Kovalenko, B M, Ariél', R A, Shchegoleva
Publikováno v:
Eksperimental'naia i klinicheskaia farmakologiia. 77(7)
It is revealed that Roncoleukin (12.5 mg/kg, intraperitoneally, 5 injections a day), Betaleukin (0.1 mg/kg, intraperitoneally, 1 time in 3 days (5 weeks)), Bestim (0.1 mg/kg, intraperitoneally, 10 injections), cycloferon (3.6 mg/kg, intraperitoneally
Publikováno v:
Arkhiv patologii. 76(2)
Experiments on 62 male albino outbred rats investigated the impact of 14-day use of the oral hepatotropic agents ademethionine and runihol in different doses in liver damage caused by a antituberculosis combination (HRZ). HRZ-induced liver damage was
Autor:
D S, Sukhanov, T I, Vinogradova, N V, Zabolotnykh, S V, Okovityĭ, S N, Vasil'eva, M L, Vitovskaia
Publikováno v:
Eksperimental'naia i klinicheskaia farmakologiia. 76(9)
The hepatoprotective action of runihol and S-adenosyl-L-methionine (ademethionine) has been studied in a group of 47 white outbred male rats with model liver injury induced by reserve antituberculosis drugs (PAS, prothionamide, cycloserine). The abil
Publikováno v:
Arkhiv patologii. 75(2)
Experiments on male albino outbred rats investigated the hepatoprotective activity of remaxol and ademethionine in liver damage caused by reserve-series antituberculosis drugs. The test drugs had a mixed action, by reducing the degree of cytolytic an
Autor:
M A, Stukova, N V, Zabolotnykh, T I, Vinogradova, V Ia, Gergert, A S, Apt, A S, Kaprel'iants, V V, Erokhin, P K, Iablonskiĭ, O I, Kiselev
Publikováno v:
Vestnik Rossiiskoi akademii meditsinskikh nauk. (11)
This review is focused on recent advances in development of new vaccines for the prevention of tuberculosis. The main reasons for lack of BCG vaccine efficacy in different populations and geographic regions are presented. Design of new vaccines based